Regulation of diabetic retinopathy by Nrf2
Regulation of diabetic retinopathy by Nrf2
批准号:
8656121
负责人:
ELIA J DUH
金额:
$44.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-05-01 至 2015-11-30
关键词:
AddressAdultAgeAttenuatedBlindnessBlood capillariesCellsDeveloped CountriesDevelopmentDiabetes MellitusDiabetic RetinopathyDiabetic mouseDiseaseDropoutDropsEndothelial CellsGenesGeneticHypoxiaIncidenceInflammationInflammatoryIschemiaLeadMeasuresMediatingMusNeurogliaOxidative StressPathogenesisPathologicPhase I Clinical TrialsPlayProcessPublic HealthReactive Oxygen SpeciesRegulationReperfusion InjuryResearchRetinaRetinalRetinal NeovascularizationRoleSignal TransductionStreptozocinSystemTestingVascular PermeabilitiesVisionVisual impairmentWild Type MouseWorkcapillarydehydroretinaldiabeticgain of functionmacular edemamouse modelnovel therapeuticsprotective effectresponseretinal ischemiatranscription factortreatment strategy
中文摘要
糖尿病视网膜病变(DR)是工业化国家工作年龄成人失明的主要原因,
由于糖尿病发病率的上升,它对公众健康的影响将变得更大-
宽糖尿病视网膜病变的视力损害由两个原因引起:视网膜血管
渗透性(其导致糖尿病性黄斑水肿)和毛细血管脱落(其导致视网膜病变)。
缺血/缺氧和随后视网膜新生血管形成的发展)。糖尿病会产生氧化
视网膜中的应激和促炎性变化,这对于糖尿病的发病机制至关重要。
视网膜病变因此,这些过程的调节对于DR的进展是重要的。
转录因子Nrf 2在抗氧化应激和炎症中具有重要的细胞保护作用。
多种疾病过程。nrf 2很容易进行药理学调节,因此其保护作用可以
增强。我们的实验室一直在研究Nrf 2在视网膜中的作用。我们发现Nrf 2系统
在视网膜对缺血-再灌注损伤的反应中起重要的保护作用。此外,我们有
初步证据表明Nrf 2在糖尿病视网膜病变中起重要作用。我们假设Nrf 2是一个
重要的保护机制,调节氧化应激和促炎性变化的视网膜,
糖尿病我们进一步假设Nrf 2调节糖尿病患者的血管通透性和毛细血管脱落。
视网膜病变,并提出以下3个目标:具体目标1。确定Nrf 2在调节
糖尿病小鼠模型中的氧化应激和促炎过程。具体目标2。确定
Nrf 2对糖尿病小鼠模型中血管通透性和毛细血管脱落的作用。具体目标3。
确定Nrf 2的药理学激活是否可防止
糖尿病视网膜病变我们预计,这些目标将使我们能够牵连Nrf 2作为一个重要的保护,
糖尿病视网膜病变的发病机制,并为这种威胁视力的疾病提供新的治疗策略。
英文摘要
Diabetic retinopathy (DR) is the leading cause of blindness in working-age adults in industrialized countries,
and its effects on public health will become even greater because of the rising incidence of diabetes world-
wide. Visual impairment in diabetic retinopathy results from two causes: increased retinal vascular
permeability (which leads to diabetic macular edema) and capillary drop-out (which leads to retinal
ischemia/hypoxia and the subsequent development of retinal neovascularization). Diabetes creates oxidative
stress and pro-inflammatory changes in the retina, which are critical for the pathogenesis of diabetic
retinopathy. As a result, the regulation of these processes is important for the progression of DR.
The transcription factor Nrf2 has an important cytoprotective role against oxidative stress and inflammation in
multiple disease processes. Nrf2 is quite amenable to pharmacologic modulation, so its protective effects can
be augmented. Our lab has been studying the role of Nrf2 in the retina. We have found that the Nrf2 system
plays a vital protective role in the retinal response to ischemia-reperfusion injury. Furthermore, we have
preliminary evidence that Nrf2 plays an important role in diabetic retinopathy. We hypothesize that Nrf2 is an
important protective mechanism regulating oxidative stress and pro-inflammatory changes in the retina in
diabetes. We further hypothesize that Nrf2 regulates vascular permeability and capillary dropout in diabetic
retinopathy and propose the following 3 aims: Specific Aim 1. Determine the role of Nrf2 in the regulation of
oxidative stress and pro-inflammatory processes in a diabetic mouse model. Specific Aim 2. Determine the
role of Nrf2 on vascular permeability and capillary drop-out in a diabetic mouse model. Specific Aim 3.
Determine if pharmacologic activation of Nrf2 protects against pathophysiologic and functional changes in
diabetic retinopathy. We anticipate that these aims will allow us to implicate Nrf2 as an important protective
mechanism in diabetic retinopathy and provide a new therapeutic strategy for this sight-threatening condition.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of diabetic retinopathy by Nrf2
-
批准号:8459393
-
项目类别:
-
资助金额:$43.4万
-
财政年份:2012
-
负责人:ELIA J DUH
-
依托单位:
Role of Nrf2 in retinal vascularization and ROP
-
批准号:8879151
-
项目类别:
-
资助金额:$39.69万
-
财政年份:2012
-
负责人:ELIA J DUH
-
依托单位:
Role of Nrf2 in retinal vascularization and ROP
-
批准号:9921391
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2012
-
负责人:ELIA J DUH
-
依托单位:
Regulation of diabetic retinopathy by Nrf2
-
批准号:8275668
-
项目类别:
-
资助金额:$45.68万
-
财政年份:2012
-
负责人:ELIA J DUH
-
依托单位:
Role of Nrf2 in retinal vascularization and ROP
-
批准号:8675257
-
项目类别:
-
资助金额:$39.69万
-
财政年份:2012
-
负责人:ELIA J DUH
-
依托单位:
Role of Nrf2 in retinal vascularization and ROP
-
批准号:8348187
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2012
-
负责人:ELIA J DUH
-
依托单位:
Role of Nrf2 in retinal vascularization and ROP
-
批准号:8519459
-
项目类别:
-
资助金额:$38.48万
-
财政年份:2012
-
负责人:ELIA J DUH
-
依托单位:
Regulation of diabetic retinopathy by Nrf2
-
批准号:8535309
-
项目类别:
-
资助金额:$14.2万
-
财政年份:2012
-
负责人:ELIA J DUH
-
依托单位:
Role of Nrf2 in retinal vascularization and ROP
-
批准号:10153791
-
项目类别:
-
资助金额:$39.71万
-
财政年份:2012
-
负责人:ELIA J DUH
-
依托单位:
Regulation of diabetic retinopathy by Nrf2
-
批准号:9187022
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2012
-
负责人:ELIA J DUH
-
依托单位:
Role and regulation of MEF2C in retinal angiogenesis
-
批准号:7391085
-
项目类别:
-
资助金额:$36.16万
-
财政年份:2007
-
负责人:ELIA J DUH
-
依托单位:
Role and regulation of MEF2C in retinal angiogenesis
-
批准号:8047979
-
项目类别:
-
资助金额:$35.07万
-
财政年份:2007
-
负责人:ELIA J DUH
-
依托单位:
Role and regulation of MEF2C in retinal angiogenesis
-
批准号:7589654
-
项目类别:
-
资助金额:$36.9万
-
财政年份:2007
-
负责人:ELIA J DUH
-
依托单位:
Role and regulation of MEF2C in retinal angiogenesis
-
批准号:7797350
-
项目类别:
-
资助金额:$36.53万
-
财政年份:2007
-
负责人:ELIA J DUH
-
依托单位:
Role and regulation of MEF2C in retinal angiogenesis
-
批准号:7243771
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2007
-
负责人:ELIA J DUH
-
依托单位:
Inhibition of CNV using a transgenic PEDF model
-
批准号:6507963
-
项目类别:
-
资助金额:$16.35万
-
财政年份:2002
-
负责人:ELIA J DUH
-
依托单位:
Inhibition of CNV using a transgenic PEDF model
-
批准号:6631455
-
项目类别:
-
资助金额:$16.35万
-
财政年份:2002
-
负责人:ELIA J DUH
-
依托单位:
Inhibition of CNV using a transgenic PEDF model
-
批准号:6790617
-
项目类别:
-
资助金额:$16.35万
-
财政年份:2002
-
负责人:ELIA J DUH
-
依托单位:
GENE EXPRESSION CHANGES IN RETINAL NEOVASCULARIZATION
-
批准号:6384241
-
项目类别:
-
资助金额:$16.69万
-
财政年份:1999
-
负责人:ELIA J DUH
-
依托单位:
GENE EXPRESSION CHANGES IN RETINAL NEOVASCULARIZATION
-
批准号:6178730
-
项目类别:
-
资助金额:$16.28万
-
财政年份:1999
-
负责人:ELIA J DUH
-
依托单位:
海外基金